Muhammad Riaz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Muhammad Riaz has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Fabio Grassia
Dept of Neurosurgery, University of Colorado Denver, Denver, United States, USA
4 shared publications - Abdul Basit Sangah
Liaquat National Hospital and Medical College, Karachi, Pakistan
1 shared publication - Aynur Aliyeva
Neuroscience Doctoral Program, Yeditepe University, Istanbul, Turkey
1 shared publication - Ceemal Fareed Khan
Department of Surgery, Aga Khan University, Karachi, Pakistan
1 shared publication - Dur E. Sameen
Department of Surgery, Jinnah Medical and Dental College, Karachi, Pakistan
1 shared publication - Edin Nevzati1 shared publication
Latest Publications
- Open Access
- 8 October 2026
- Published by MDPI AG in Preprints.org
Withdrawn: Multimodal Artificial Intelligence-Driven Clinical Decision Support for TBI Severity Assessment, Post-Traumatic Seizure Prediction, and Personalized Management
This preprint has been withdrawn at the request of the author due to concerns regarding the confidentiality of data used by pharmaceutical companies.
- 8 October 2026
- Published by MDPI AG in Preprints.org
Open AccessWithdrawn: Multimodal Artificial Intelligence-Driven Clinical Decision Support for TBI Severity Assessment, Post-Traumatic Seizure Prediction, and Personalized Management
This preprint has been withdrawn at the request of the author due to concerns regarding the confidentiality of data used by pharmaceutical companies.
- Open Access
- 22 April 2026
- Published by MDPI AG in Preprints.org
Surgical Decision-Making in Trigeminal Neuralgia: A Focused Evidence Synthesis and Proposed Clinical Algorithm
Background: Trigeminal neuralgia (TN) is a severe neuropathic pain disorder for which a significant proportion of patients require surgical intervention following failure of pharmacological therapy. Despite the availability of multiple surgical and neuromodulatory options, there is no unified, evidence-informed framework to guide procedure selection across different clinical scenarios. Objective: To synthesize contemporary evidence on surgical and neuromodulatory interventions for TN and to develop a structured clinical decision algorithm to support patient-specific management. Methods: A focused evidence synthesis was conducted using PubMed/MEDLINE, Embase, Web of Science, and Cochrane databases for studies published between January 2016 and January 2026. Eligibility was restricted to high-level evidence, including systematic reviews, meta-analyses, large clinical series, and consensus guidelines. Data on study design, patient population, intervention type, outcomes, and complications were extracted and synthesized narratively. Based on the synthesized evidence, a stepwise clinical decision algorithm was developed. Results: Six high-quality sources met the inclusion criteria. Microvascular decompression (MVD) demonstrated the highest rates of initial pain freedom (85–96%) and the lowest long-term recurrence, particularly in patients with MRI-confirmed arterial neurovascular conflict. Stereotactic radiosurgery (SRS) offered a favorable safety profile with moderate durability but higher recurrence rates. Percutaneous procedures provided effective minimally invasive alternatives, with selection guided by patient-specific factors. Peripheral nerve stimulation was identified as a viable option in refractory cases. Key limitations in the evidence base include the absence of randomized comparative trials and heterogeneity in outcome reporting. Conclusions: Current evidence supports a stratified, patient-centered approach to the surgical management of TN. The proposed clinical algorithm integrates available data into a structured framework to support decision-making in clinical practice. Further prospective validation and standardized outcome reporting are required to strengthen the evidence base.
- 22 April 2026
- Published by MDPI AG in Preprints.org
Open AccessSurgical Decision-Making in Trigeminal Neuralgia: A Focused Evidence Synthesis and Proposed Clinical Algorithm
Background: Trigeminal neuralgia (TN) is a severe neuropathic pain disorder for which a significant proportion of patients require surgical intervention following failure of pharmacological therapy. Despite the availability of multiple surgical and neuromodulatory options, there is no unified, evidence-informed framework to guide procedure selection across different clinical scenarios. Objective: To synthesize contemporary evidence on surgical and neuromodulatory interventions for TN and to develop a structured clinical decision algorithm to support patient-specific management. Methods: A focused evidence synthesis was conducted using PubMed/MEDLINE, Embase, Web of Science, and Cochrane databases for studies published between January 2016 and January 2026. Eligibility was restricted to high-level evidence, including systematic reviews, meta-analyses, large clinical series, and consensus guidelines. Data on study design, patient population, intervention type, outcomes, and complications were extracted and synthesized narratively. Based on the synthesized evidence, a stepwise clinical decision algorithm was developed. Results: Six high-quality sources met the inclusion criteria. Microvascular decompression (MVD) demonstrated the highest rates of initial pain freedom (85–96%) and the lowest long-term recurrence, particularly in patients with MRI-confirmed arterial neurovascular conflict. Stereotactic radiosurgery (SRS) offered a favorable safety profile with moderate durability but higher recurrence rates. Percutaneous procedures provided effective minimally invasive alternatives, with selection guided by patient-specific factors. Peripheral nerve stimulation was identified as a viable option in refractory cases. Key limitations in the evidence base include the absence of randomized comparative trials and heterogeneity in outcome reporting. Conclusions: Current evidence supports a stratified, patient-centered approach to the surgical management of TN. The proposed clinical algorithm integrates available data into a structured framework to support decision-making in clinical practice. Further prospective validation and standardized outcome reporting are required to strengthen the evidence base.
- Open Access
- 15 April 2026
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 168 (1) , 96
Letter to the editor regarding “Electrophysiological monitoring of the trigeminal nerve sensory root using sensory-masseter response for microvascular decompression in trigeminal neuralgia”
- 15 April 2026
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 168 (1) , 96
Open AccessLetter to the editor regarding “Electrophysiological monitoring of the trigeminal nerve sensory root using sensory-masseter response for microvascular decompression in trigeminal neuralgia”
- Open Access
- 27 March 2026
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 17, 170
Preoperative embolization in intracranial meningioma surgery: An updated systematic review and meta-analysis
Background: Intracranial meningiomas are vascular tumors often causing significant intraoperative blood loss. Preoperative embolization (POE) aims to reduce vascularity and improve outcomes, though its efficacy is debated. This systematic review and meta-analysis evaluate the impact of POE on operative and postoperative outcomes in intracranial meningioma surgery. Methods: Following Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines, a literature search from 2017 to 2025 identified 13 English-language, non-randomized studies comparing POE to no embolization. Outcomes included intraoperative blood loss, operative time, extent of resection, complications, and tumor recurrence. Due to heterogeneity, a meta-analysis was performed where possible, supplemented by a narrative synthesis. Risk of bias assessment was performed. Results: Meta-analysis revealed that POE significantly reduced complications (odds ratio [OR] 0.68, 95% confidence interval [CI] 0.53–0.88) and increased the likelihood of achieving gross total resection (GTR) (pooled OR 0.61, 95% CI 0.46–0.80). In contrast, findings on intraoperative blood loss and operative time were highly inconsistent with extreme heterogeneity. Tumor recurrence data were extremely limited, reported in only on study, precluding synthesis on long-term outcomes. Significant methodological variability was identified. Conclusion: POE consistently improves the likelihood of achieving GTR in intracranial meningiomas. However, its benefits in reducing intraoperative blood loss and operative time remain inconsistent. Neurosurgeons should consider POE when maximal resection is the primary surgical goal, especially for highly vascular tumors. Future research requires robust designs, such as matched-cohort studies or randomized controlled trials, to definitively establish its precise role.
- 27 March 2026
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 17, 170
Open AccessPreoperative embolization in intracranial meningioma surgery: An updated systematic review and meta-analysis
Background: Intracranial meningiomas are vascular tumors often causing significant intraoperative blood loss. Preoperative embolization (POE) aims to reduce vascularity and improve outcomes, though its efficacy is debated. This systematic review and meta-analysis evaluate the impact of POE on operative and postoperative outcomes in intracranial meningioma surgery. Methods: Following Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines, a literature search from 2017 to 2025 identified 13 English-language, non-randomized studies comparing POE to no embolization. Outcomes included intraoperative blood loss, operative time, extent of resection, complications, and tumor recurrence. Due to heterogeneity, a meta-analysis was performed where possible, supplemented by a narrative synthesis. Risk of bias assessment was performed. Results: Meta-analysis revealed that POE significantly reduced complications (odds ratio [OR] 0.68, 95% confidence interval [CI] 0.53–0.88) and increased the likelihood of achieving gross total resection (GTR) (pooled OR 0.61, 95% CI 0.46–0.80). In contrast, findings on intraoperative blood loss and operative time were highly inconsistent with extreme heterogeneity. Tumor recurrence data were extremely limited, reported in only on study, precluding synthesis on long-term outcomes. Significant methodological variability was identified. Conclusion: POE consistently improves the likelihood of achieving GTR in intracranial meningiomas. However, its benefits in reducing intraoperative blood loss and operative time remain inconsistent. Neurosurgeons should consider POE when maximal resection is the primary surgical goal, especially for highly vascular tumors. Future research requires robust designs, such as matched-cohort studies or randomized controlled trials, to definitively establish its precise role.
- Top Cited PapersOpen Access
- 7 March 2026
- Published by Elsevier in Brain and Spine
- Vol. 6
AI at the Sella Turcica: Multi-Model Large Language Model Evaluation in Pituitary Adenomas
- 7 March 2026
- Published by Elsevier in Brain and Spine
- Vol. 6
Top Cited PapersOpen AccessAI at the Sella Turcica: Multi-Model Large Language Model Evaluation in Pituitary Adenomas
- Open Access
- 3 November 2025
- Published by Elsevier in World Neurosurgery
- Vol. 205, 124612
Letter to the Editor Regarding “YouTube as a Source of Patient Education in Medulloblastoma: How Reliable Is It?”
- 3 November 2025
- Published by Elsevier in World Neurosurgery
- Vol. 205, 124612
Open AccessLetter to the Editor Regarding “YouTube as a Source of Patient Education in Medulloblastoma: How Reliable Is It?”